The store will not work correctly when cookies are disabled.
3-(6-Chloro-1-thia-3, 4, 9-triaza-fluoren-2-yl)-2-pyridin-2-yl-thiazolidin-4-one
ID: ALA2297410
PubChem CID: 76334929
Max Phase: Preclinical
Molecular Formula: C17H10ClN5OS2
Molecular Weight: 399.89
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CSC(c2ccccn2)N1c1nnc2c3cc(Cl)ccc3nc-2s1
Standard InChI: InChI=1S/C17H10ClN5OS2/c18-9-4-5-11-10(7-9)14-15(20-11)26-17(22-21-14)23-13(24)8-25-16(23)12-3-1-2-6-19-12/h1-7,16H,8H2
Standard InChI Key: BGXJBFIMRZPJSZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
19.6249 -10.3226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6208 -11.1398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3967 -11.3963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2079 -10.3263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2068 -11.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9148 -11.5548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9130 -9.9174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4034 -10.0740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8776 -10.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6888 -10.6604 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.0268 -9.9170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5476 -9.2516 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7381 -9.3338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8401 -9.8365 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3809 -10.4491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1294 -10.1213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0489 -9.3080 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.2506 -9.1334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2046 -11.2471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9223 -8.3851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5001 -9.9179 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
23.4072 -7.7293 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0795 -6.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2665 -6.8912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7822 -7.5546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1125 -8.2998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 9 2 0
8 1 1 0
4 5 2 0
5 6 1 0
6 2 2 0
1 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 8 2 0
11 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
15 19 2 0
18 20 1 0
4 21 1 0
20 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 399.89 | Molecular Weight (Monoisotopic): 399.0015 | AlogP: 4.02 | #Rotatable Bonds: 2 |
Polar Surface Area: 71.87 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.72 | CX LogP: 3.17 | CX LogD: 3.17 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.51 | Np Likeness Score: -1.75 |
References
1. Agrawal OP, Sonar PK, Saraf SK. (2013) 4-Thiazolidinone and 1-thia-3,4,9-triaza fluorene conjugates: synthesis, characterization and antimicrobial screening, 22 (4): [10.1007/s00044-012-0200-1] |